{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825894544634496.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/jps.10412"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022354916312801?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022354916312801?httpAccept=text/plain"}}],"dc:title":[{"@value":"Lecithin-based oil-in-water microemulsions for parenteral use: Pseudoternary phase diagrams, characterization and toxicity studies"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825894544634496","@type":"Researcher","foaf:name":[{"@value":"Marco Antonio Moreno"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894544634497","@type":"Researcher","foaf:name":[{"@value":"M Paloma Ballesteros"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894544634498","@type":"Researcher","foaf:name":[{"@value":"Paloma Frutos"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00223549"}],"prism:publicationName":[{"@value":"Journal of Pharmaceutical Sciences"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2003-07","prism:volume":"92","prism:number":"7","prism:startingPage":"1428","prism:endingPage":"1437"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022354916312801?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022354916312801?httpAccept=text/plain"}],"createdAt":"2003-06-17","modifiedAt":"2019-03-20","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282679617198848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current Status of Drug Delivery Systems for Antifungal Drugs"},{"@language":"ja","@value":"深在性真菌症に対するDDS"},{"@language":"ja-Kana","@value":"シンザイセイ シンキンショウ ニ タイスル DDS"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/jps.10412"},{"@type":"CROSSREF","@value":"10.2745/dds.27.93_references_DOI_QCNHRtaqba07lPYcqXiZGy6j701"}]}